Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Telma-MCT 50/12.5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)

Overview Telma-MCT 50/12.5 Tablet ER

Micardis Plus 50/12.5 mg Extended-Release tablets combine two medications to manage hypertension. This treatment lowers blood pressure by widening blood vessels and improving the heart's pumping efficiency. It also promotes fluid and electrolyte excretion. Micardis Plus can be taken with or without food, but consistent timing maximizes effectiveness. Increased urination is a common effect; consider daytime dosing or at least four hours before sleep to minimize nighttime bathroom trips. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely. Continue taking this medication as directed. Typical side effects include nausea, diarrhea, indigestion, headache, and lightheadedness. Regular monitoring of kidney function and electrolyte levels is essential. Optimal results require combining this medication with lifestyle modifications such as a balanced diet, regular physical activity, and smoking cessation. Increased fluid intake is recommended to alleviate dryness and thirst. Inform your doctor of any pregnancy, circulatory disorders, liver or kidney issues, or other medications you are currently taking, as interactions may affect the drug's efficacy.

Primary Ingredients of Telma-MCT 50/12.5 Tablet ER

No information provided. Please provide the text you wish to be rewritten.

Uses of Telma-MCT 50/12.5 Tablet ER

Elevated blood pressure

Major Benefits of Telma-MCT 50/12.5 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 50/12.5 Extended-Release Tablets can be administered with or without food, although consistent daily timing is recommended.

Common Side effects of Telma-MCT 50/12.5 Tablet ER:

  • Nausea
  • Diarrhea
  • Upset stomach
  • Headache
  • Dizziness
  • Cold extremities
  • Numbness of extremity
  • Increased blood lipid level
  • Slow heart rate
  • Decreased blood pressure

How to use Telma-MCT 50/12.5 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 50/12.5 Extended-Release tablets can be consumed with or without food, although consistent timing is recommended.

How Telma-MCT 50/12.5 Tablet ER works:

Chlorthalidone, a diuretic, facilitates urinary excretion of excess fluid and select electrolytes. Its long-term effects include vasodilation and enhanced circulation. Metoprolol succinate, a beta-adrenergic blocker, reduces cardiac output by decreasing heart rate. Telmisartan, an angiotensin receptor blocker, lowers blood pressure through vasodilation by inhibiting angiotensin II.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Telma-MCT 50/12.5 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telma-MCT 50/12.5mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Telma-MCT 50/12.5 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telma-MCT 50/12.5 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Telma-MCT 50/12.5 mg Extended-Release tablets, as dose modification may be necessary. Physician consultation is advised; the medication is generally unsuitable for such individuals.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Telma-MCT 50/12.5 ER tablets; dosage modification may be necessary. Medical advice is recommended. The use of Telma-MCT 50/12.5 ER tablets is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Telma-MCT 50/12.5 Tablet ER :

Should you forget to take a Telma-MCT 50/12.5 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telma-MCT 50/12.5 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart
Telma-MCT 50/12.5 Tablet ...
162
MRP 187
13% off